Third Quarter 2025 Financial Results: Total revenue for the quarter ended September 30, 2025 was $134.2 million, up 12% from $119.8 million in the same period of 2024. This growth and operational ...

The controlled multi-centre, randomised, prospective trial is investigating the therapy in kidney transplant recipients.

Details of the novel pharmacokinetic assay for measuring SAB-142.

Post Marketing Study to Evaluate the Role of CYTOGAM in the Reduction of Risk of Late CMV Disease Following the Conclusion of ...

Southeast Asian island nation Timor-Leste or East Timor, which had previously been considered rabies-free, confirmed its ...

First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...

Conference Call Scheduled for November 5, 2025, at 4:30 p.m. ETRAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2025 (GLOBE ...

By Tom Latek Kentucky Today Public health officials are warning Kentuckians that since it’s fall, bats are going to become ...

Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...

Health officials said no humans encountered the bats, but a dog that was up to date on vaccinations was exposed.

Immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) is a rare disease that affects the filtering units in your kidneys (glomeruli). There are many types of glomerular diseases.